12 der blev behandlet med infliximab, som fik mindst en kort infusion, opstod infusionsrelaterede reaktioner hos 15% af patienterne, og alvorlige infusionsreaktioner opstod hos 0, 4% af patienterne.
Of the infliximab-treated patients who received at least one shortened infusion, infusion-related reactions occurred in 15% of patients and serious infusion reactions occurred in 0.4% of patients.